Document is current
Any future updates will be listed below
-
Authors
Horňák, Tomáš
Žáčková, Daniela
Mayer, Jiří
-
Funding
Funding for this research was provided by:
Ministerstvo Školství, Mládeže a Tělovýchovy (MUNI/A/1685/2024, MUNI/A/1685/2024, MUNI/A/1685/2024)
- License Information
-
More Information
Article History
Received: 29 July 2025
Accepted: 18 October 2025
First Online: 5 November 2025
Declarations
:
: Approved by Ethics Committee of University Hospital Brno.
: TH served on a speaker’s bureau for Novartis and received travel grant from Novartis and Angelini Pharma. DŽ served as a member of advisory board for Novartis, Zentiva, Ascentage, Enliven Therapeutics, served on a speaker’s bureau for Novartis and Angelini Pharma, served as a consultant for Novartis and Angelini Pharma. JM Received research support from Novartis and BMS.
